A double blind experiment is a design in which neither the subjects nor the people interacting with them or measuring the response know which treatment each subject received, preventing expectations on either side from biasing the results (AP Stats Topic 3.5, learning objective 3.5.C).
In a double blind experiment, two groups are kept in the dark about treatment assignments. The subjects don't know whether they got the real treatment or the placebo, and the researchers who administer the treatments or measure the response don't know either. Usually a third party (like a pharmacist coding the pills) holds the key and reveals it only after the data are collected.
Why go to all that trouble? Because expectations change behavior. A subject who knows they got the real drug might report feeling better just because they expect to (the placebo effect). A researcher who knows which subjects got the drug might unconsciously rate their symptoms more favorably or treat them differently. Blinding both sides cuts off both sources of bias at once. That's the whole idea, and on the AP exam you need to be able to say it in exactly those terms: who is blinded, and what specific bias each layer of blinding prevents.
Double blinding lives in Unit 3: Collecting Data, Topic 3.5 (Introduction to Experimental Design). It directly supports learning objective 3.5.C (compare experimental designs and methods), which asks you to distinguish single-blind from double-blind setups, and it connects to 3.5.B because blinding is one way a well-designed experiment controls potential confounding variables. Unit 3 is where AP Stats tests whether you understand that how you collect data determines what conclusions you can draw. Blinding is one of the clearest examples, since it's not about fancy math at all. It's about making sure the measured difference between groups comes from the treatment, not from anyone's expectations.
Keep studying AP Statistics Unit 3
Placebo (Unit 3)
Blinding usually requires a placebo. If the control group got nothing at all, subjects would know which group they were in, so a fake treatment that looks identical to the real one is what makes the blind possible.
Confounding Variable (Unit 3)
Expectation is itself a potential confounder. If only the treatment group expects to improve, you can't tell whether the drug worked or the belief did. Double blinding makes expectations equal across groups so they can't explain the difference.
Random Assignment (Unit 3)
Random assignment and blinding fix different problems. Randomization balances variables that exist before the experiment starts (age, health, habits), while blinding controls bias that creeps in during the experiment. A well-designed experiment often needs both.
Bias (Unit 3)
Double blinding is a bias-control tool, the experimental cousin of good sampling technique. Just as a bad sampling method produces estimates that systematically miss the truth, unblinded measurement produces responses that systematically lean toward what people expect.
Double blinding shows up two ways. In multiple choice, you'll get a scenario (a drug trial, a taste test, a therapy study) and be asked whether it's single-blind, double-blind, or not blind, or asked why blinding improves the design. In experimental design FRQs, you may be asked to describe a well-designed experiment, and stating that the experiment is double blind, plus who doesn't know what and why that matters, is how you earn full credit. The classic trap is vague language. "It's double blind so there's no bias" scores nothing. You need something like "neither the subjects nor the doctors measuring blood pressure know who received the drug, so neither group's expectations can influence the recorded responses." No released FRQ requires the phrase verbatim, but blinding is a standard component of strong answers on design questions.
Count who's in the dark. In a single-blind experiment, only one side is blinded. Either the subjects don't know their treatment but the researchers do, or the researchers measuring the response don't know but the subjects do. In a double blind experiment, both sides are blinded. Single blinding stops one source of expectation bias; double blinding stops both. On the exam, read carefully to see whether the person evaluating the outcome knows the assignments. That detail is usually what separates the two.
In a double blind experiment, neither the subjects nor the researchers who interact with them or measure the response know who received which treatment.
Blinding the subjects controls the placebo effect, and blinding the researchers prevents their expectations from influencing how they treat subjects or record results.
Double blinding usually requires a placebo, since the control group needs something that looks identical to the real treatment.
Blinding and random assignment are not the same thing. Randomization balances pre-existing differences between groups, while blinding controls bias during the experiment.
On FRQs, never just write 'double blind.' Say who doesn't know what, and name the specific bias that blinding prevents.
A single-blind experiment hides assignments from only one side (subjects or researchers); a double blind experiment hides them from both.
It's an experimental design where neither the subjects nor the researchers administering treatments or measuring responses know who got which treatment. It appears in Topic 3.5 of Unit 3 and supports learning objective 3.5.C on comparing experimental methods.
No. Double blinding only controls bias from expectations, on both the subject side and the researcher side. It doesn't fix a bad sample, missing randomization, or confounding variables built into the design, which is why a well-designed experiment also needs comparison groups, random assignment, and replication.
In a single-blind experiment, only one party (either the subjects or the researchers) is unaware of the treatment assignments. In a double blind experiment, both are unaware. Double blinding controls expectation bias from both directions.
If the control group received nothing, subjects could figure out which group they were in and the blind would break. A placebo that looks, tastes, or feels identical to the real treatment keeps subjects (and often researchers) from telling the groups apart.
No. Random assignment decides who gets which treatment and balances pre-existing differences between groups. Blinding hides who got which treatment so expectations can't influence behavior or measurement. Strong experiments use both, but they solve different problems.